Latest News
- June 05, 2025Join CBCC at CPHI China 2025
- June 02, 2025Successfully completed a Phase 1a study for a US-based Innovator Biotech Company!
- May 26, 2025ANDA application for Paclitaxel Injection (Albumin bound) supported by CBCC has received Marketing Authorization from the USFDA
- May 20, 2025We’re Exhibiting at BIO 2025! Visit our booth #3480
- May 15, 2025Join CBCC Global Research at #ASCO25
November 08, 2022
MediPrint™ Ophthalmics Announces Its SIGHT-2 Phase 2b Clinical Study with CBCC
CBCC Global Research looks forward to working with MediPrint Ophthalmics on this important study to help move #ophthalmic drug delivery forward. The #drugeluting contact lens platform is an important option for millions of patients.
We also congratulate MediPrint on the recent move and manufacturing scale-up.
Please see the press release issued by MediPrint for additional details: https://lnkd.in/djW7-GBh